BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 25840724)

  • 1. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease.
    Pothoven KL; Norton JE; Hulse KE; Suh LA; Carter RG; Rocci E; Harris KE; Shintani-Smith S; Conley DB; Chandra RK; Liu MC; Kato A; Gonsalves N; Grammer LC; Peters AT; Kern RC; Bryce PJ; Tan BK; Schleimer RP
    J Allergy Clin Immunol; 2015 Sep; 136(3):737-746.e4. PubMed ID: 25840724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H3N2 influenza virus infection enhances oncostatin M expression in human nasal epithelium.
    Tian T; Zi X; Peng Y; Wang Z; Hong H; Yan Y; Guan W; Tan KS; Liu J; Ong HH; Kang X; Yu J; Ong YK; Thong KT; Shi L; Ye J; Wang DY
    Exp Cell Res; 2018 Oct; 371(2):322-329. PubMed ID: 30142324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease.
    Pothoven KL; Norton JE; Suh LA; Carter RG; Harris KE; Biyasheva A; Welch K; Shintani-Smith S; Conley DB; Liu MC; Kato A; Avila PC; Hamid Q; Grammer LC; Peters AT; Kern RC; Tan BK; Schleimer RP
    J Allergy Clin Immunol; 2017 Jun; 139(6):1966-1978.e9. PubMed ID: 27993536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4.
    Soyka MB; Wawrzyniak P; Eiwegger T; Holzmann D; Treis A; Wanke K; Kast JI; Akdis CA
    J Allergy Clin Immunol; 2012 Nov; 130(5):1087-1096.e10. PubMed ID: 22840853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression.
    Steelant B; Farré R; Wawrzyniak P; Belmans J; Dekimpe E; Vanheel H; Van Gerven L; Kortekaas Krohn I; Bullens DMA; Ceuppens JL; Akdis CA; Boeckxstaens G; Seys SF; Hellings PW
    J Allergy Clin Immunol; 2016 Apr; 137(4):1043-1053.e5. PubMed ID: 26846377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling.
    Cho SH; Kim DW; Lee SH; Kolliputi N; Hong SJ; Suh L; Norton J; Hulse KE; Seshadri S; Conley DB; Kern RC; Tan BK; Peters A; Grammer LC; Schleimer RP
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):601-6. PubMed ID: 26266960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M Contributes to Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps.
    Carsuzaa F; Bequignon E; Bartier S; Coste A; Dufour X; Bainaud M; Lecron JC; Louis B; Tringali S; Favot L; Fieux M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor necrosis factor family molecules LIGHT and lymphotoxins in sinus mucosa of patients with chronic rhinosinusitis with or without nasal polyps.
    Hwang JW; Kim YC; Lee HY; Lee KJ; Kim TH; Lee SH
    Cytokine; 2021 Dec; 148():155594. PubMed ID: 34083106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase activity is a novel target for epithelial barrier defects in patients with eosinophilic chronic rhinosinusitis with nasal polyps.
    Duan S; Han X; Jiao J; Wang M; Li Y; Wang Y; Zhang L
    Clin Exp Allergy; 2023 Apr; 53(4):443-454. PubMed ID: 36458367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis.
    Steelant B; Wawrzyniak P; Martens K; Jonckheere AC; Pugin B; Schrijvers R; Bullens DM; Vanoirbeek JA; Krawczyk K; Dreher A; Akdis CA; Hellings PW
    J Allergy Clin Immunol; 2019 Nov; 144(5):1242-1253.e7. PubMed ID: 31082457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
    Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
    Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tc17/IL-17A Up-Regulated the Expression of MMP-9 via NF-κB Pathway in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis.
    Chen X; Chang L; Li X; Huang J; Yang L; Lai X; Huang Z; Wang Z; Wu X; Zhao J; Bellanti JA; Zheng SG; Zhang G
    Front Immunol; 2018; 9():2121. PubMed ID: 30283454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of IFN-γ, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells in chronic rhinosinusitis with nasal polyps.
    Jiao J; Duan S; Meng N; Li Y; Fan E; Zhang L
    Clin Exp Allergy; 2016 Mar; 46(3):449-60. PubMed ID: 26399381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases.
    Sugita K; Kabashima K
    J Leukoc Biol; 2020 May; 107(5):749-762. PubMed ID: 32108379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of papillary mucosa folds and enhancement of epithelial barrier in odontogenic sinusitis.
    Zhang Y; Lan F; Li Y; Wang C; Zhang L
    Int Forum Allergy Rhinol; 2019 Nov; 9(11):1281-1288. PubMed ID: 30620087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps.
    Wang BF; Cao PP; Norton JE; Poposki JA; Klingler AI; Suh LA; Carter R; Huang JH; Bai J; Stevens WW; Tan BK; Peters AT; Grammer LC; Conley DB; Welch KC; Liu Z; Kern RC; Kato A; Schleimer RP
    J Allergy Clin Immunol; 2023 May; 151(5):1379-1390.e11. PubMed ID: 36623776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial genes in chronic rhinosinusitis with and without nasal polyps.
    Richer SL; Truong-Tran AQ; Conley DB; Carter R; Vermylen D; Grammer LC; Peters AT; Chandra RK; Harris KE; Kern RC; Schleimer RP
    Am J Rhinol; 2008; 22(3):228-34. PubMed ID: 18588753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps.
    Pace E; Scafidi V; Di Bona D; Siena L; Chiappara G; Ferraro M; La Grutta S; Gallina S; Speciale R; Ballacchino A; Bachert C; Bousquet J; Gjomarkaj M
    Allergy; 2012 Jul; 67(7):878-86. PubMed ID: 22583192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue factor and tissue factor pathway inhibitor in nasal mucosa and nasal secretions of chronic rhinosinusitis with nasal polyp.
    Shimizu S; Ogawa T; Takezawa K; Tojima I; Kouzaki H; Shimizu T
    Am J Rhinol Allergy; 2015; 29(4):235-42. PubMed ID: 26163243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial Cell-Derived Cytokines Contribute to the Pathophysiology of Eosinophilic Chronic Rhinosinusitis.
    Kouzaki H; Matsumoto K; Kato T; Tojima I; Shimizu S; Shimizu T
    J Interferon Cytokine Res; 2016 Mar; 36(3):169-79. PubMed ID: 26540312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.